Incidence and Possible Clinical Significance of K- ras Oncogene Activation in Adenocarcinoma of the Human Lung

作者: S. Rodenhuis , S. S. Wagenaar , W. J. Mooi , A. J. M. Boot , R. J. C. Slebos

DOI:

关键词:

摘要: 47 tumor samples, 45 of which were obtained at thoracotomy for non-small cell lung cancer examined mutational activation the oncogenes H-ras, K-ras, and N-ras. A novel, highly sensitive assay based on oligonucleotide hybridization following an in vitro amplification step was employed. ras gene mutations present nine 35 adenocarcinomas (all K-ras), two metastases colorectal (1 x 1 N-ras) one adenocarcinoma sample autopsy (H-ras). All K-ras H-ras either position or 2 codon 12, while N-ras mutation 61. The potential clinical significance analyzed using combined results this our earlier study (S. Rodenhuis et al., New Engl. J. Med., 317: 929-935, 1987). Lung with tended to be smaller less likely have spread regional lymph nodes presentation. With a median follow up 10 months, survival data are still immature. None six nonsmokers had only four who stopped smoking more than 5 years before. We conclude that is about third event may direct result carcinogenic ingredients tobacco smoke. Studies involving larger numbers patients required confirm association inverse relation progression.

参考文章(11)
Sjoerd Rodenhuis, Oncogenes and Human Lung Cancer Cancer treatment and research. ,vol. 45, pp. 89- 106 ,(1989) , 10.1007/978-1-4613-1593-3_6
Johannes L. Bos, The ras gene family and human carcinogenesis Mutation Research/Reviews in Genetic Toxicology. ,vol. 195, pp. 255- 271 ,(1988) , 10.1016/0165-1110(88)90004-8
J.L. Bos, M. Veriaan-de Vries, A.M. Jansen, G.H. Veeneman, J.H. van Boom, A.J. van der Eb, Three different mutations in codon 61 of the human N- ras gene detected by synthetic oligonucleotide hybridization Nucleic Acids Research. ,vol. 12, pp. 9155- 9163 ,(1984) , 10.1093/NAR/12.23.9155
Isabel Guerrero, Angel Pellicer, Mutational activation of oncogenes in animal model systems of carcinogenesis (MTR 07217) Mutation Research/Reviews in Genetic Toxicology. ,vol. 185, pp. 293- 308 ,(1987) , 10.1016/0165-1110(87)90021-2
R. Saiki, S Scharf, F Faloona, K. Mullis, G. Horn, H. Erlich, N Arnheim, Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia Science. ,vol. 230, pp. 1350- 1354 ,(1985) , 10.1126/SCIENCE.2999980
G. McMahon, L. Hanson, J. J. Lee, G. N. Wogan, Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1 Proceedings of the National Academy of Sciences of the United States of America. ,vol. 83, pp. 9418- 9422 ,(1986) , 10.1073/PNAS.83.24.9418
Mariano Barbacid, Mutagens, oncogenes and cancer Trends in Genetics. ,vol. 2, pp. 188- 192 ,(1986) , 10.1016/0168-9525(86)90222-2
Matty Verlaan-de Vries, Marianne E. Bogaard, Hans van den Elst, Jaques H. van Boom, Alex J. van der Eb, Johannes L. Bos, A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides. Gene. ,vol. 50, pp. 313- 320 ,(1986) , 10.1016/0378-1119(86)90335-5
Roel Nusse, Johannes W. G. Janssen, John G. Collard, Ada C. M. Steenvoorden, Oncogene Activation in Human Myeloid Leukemia Cancer Research. ,vol. 45, pp. 3262- 3267 ,(1985)